The natural breakthrough: phytochemicals as potent therapeutic agents against spinocerebellar ataxia type 3

The natural breakthrough: phytochemicals as potent therapeutic agents against spinocerebellar ataxia type 3

Abstract There is no FDA-approved drug for neurological disorders like spinocerebellar ataxia type 3. CAG repeats mutation in the ATXN3 gene, causing spinocerebellar ataxia type 3 disease. Symptoms include sleep cycle disturbance, neurophysiological abnormalities, autonomic dysfunctions, and depress...

Full description

Bibliographic Details
Main Authors: Muhammad Naveed, Nouman Ali, Tariq Aziz, Nimra Hanif, Mahnoor Fatima, Imran Ali, Metab Alharbi, Abdullah F. Alasmari, Thamer H. Albekairi
Format: Article
Language:English
Published: Nature Portfolio 2024-01-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-024-51954-3

Internet

https://doi.org/10.1038/s41598-024-51954-3

Similar Items